- Forums
- ASX - By Stock
- IXC
- Ann: Phase III Clinical Trial Update and New IIH Market Analysis
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-179
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
-0.010(11.1%) |
Mkt cap ! $6.012M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 8.0¢ | $66 | 827 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5423 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5423 | 0.080 |
1 | 84879 | 0.076 |
1 | 500000 | 0.040 |
1 | 70001 | 0.036 |
1 | 100001 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 5000 | 1 |
0.100 | 7400 | 2 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 10.04am 12/11/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online